REGENXBIO Inc.

RGNX · XNAS

CIK 1590877fmd_177W0WSHK65PBBHWF7XJ3HM2HVManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.